BioCentury
ARTICLE | Company News

Murex Pharmaceuticals, Gene Network Sciences deal

June 5, 2006 7:00 AM UTC

Murex and Gene Network partnered to create in silico models to identify and validate cancer targets. The deal combines Murex's molecular diagnostic capabilities for cancer and Gene Network's pathway i...